Skip to main content
Livermore
Livermore
ZHEN

Quadrant Capital Group LLC

SEC CIK
0001650717
Latest filing
Aug 14, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of SRPT by Quadrant Capital Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,157−100.0%Sold outHolders
Q1 20261,157$25.2K<0.1%−31−2.6%ReducedHolders
Q4 20251,188$25.6K<0.1%−23−1.9%ReducedHolders
Q3 20251,211$23.3K<0.1%−12,066−90.9%ReducedHolders
Q2 202513,277$227.0K<0.1%+12,706+2,225.2%AddedHolders
Q1 2025571$36.4K<0.1%−271−32.2%ReducedHolders
Q4 2024842$102.4K<0.1%−24−2.8%ReducedHolders
Q3 2024866$108.2K<0.1%+303+53.8%AddedHolders
Q2 2024563$89.0K<0.1%+482+595.1%AddedHolders
Q1 202481$10.5K<0.1%+12+17.4%AddedHolders
Q4 202369$6.65K<0.1%+31+81.6%AddedHolders
Q3 202338$4.61K<0.1%+1+2.7%AddedHolders
Q2 202337$4.24K<0.1%−90−70.9%ReducedHolders
Q1 2023127$17.5K<0.1%+95+296.9%AddedHolders
Q4 202232$4.15K<0.1%−25−43.9%ReducedHolders
Q3 202257$6.00K<0.1%−89−61.0%ReducedHolders
Q2 2022146$11.0K<0.1%−163−52.8%ReducedHolders
Q1 2022309$24.0K<0.1%−465−60.1%ReducedHolders
Q4 2021774$70.0K<0.1%−7−0.9%ReducedHolders
Q3 2021781$72.0K<0.1%+600+331.5%AddedHolders
Q2 2021181$14.0K<0.1%+142+364.1%AddedHolders
Q1 202139$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.